Agency to discuss results of report, as well as pending 2018 pilot project designed to modernize its hiring practices.
The level of frustration that mangers at the US FDA have with the agency’s hiring practices probably can’t be overstated. One individual in the agency’s executive leadership has "no idea" how to evaluate a center's hiring performance, while a hiring manager noted that there is "a profound disconnect of mission" in recruiting and retaining talented staff.
These were just a few of the rather scathing assessments of FDA's hiring process in a Nov. 15
Recent studies show that spaceflight can significantly weaken astronauts’ immune systems, making them more susceptible to infections and health complications during and after missions. Understanding these changes is crucial for ensuring the safety of future long-duration space travelers.
Recent ODAC meetings suggest the FDA will expand focus beyond applications with pending approval decisions to refining trial designs and drug labels for competitors.
The US FDA Commissioner pushed for a rebalancing of the US’s pharmaceutical supply chains while also stressing that there is a role for US-China commerce that would be risky to compromise.
Recent ODAC meetings suggest the FDA will expand focus beyond applications with pending approval decisions to refining trial designs and drug labels for competitors.
The US FDA Commissioner pushed for a rebalancing of the US’s pharmaceutical supply chains while also stressing that there is a role for US-China commerce that would be risky to compromise.
